Figure 3From: Serum TFF3 may be a pharamcodynamic marker of responses to chemotherapy in gastrointestinal cancers Measurement of serum TFF3 levels in colorectal cancer patients. Serum TFF3 levels were compared in colorectal cancer patients. The significant ratios with Pā<ā0.05 between 2 groups (clinical stage III/IV) and another 2 groups (clinical stage I-II/IV) (a) The significant ratios with Pā<ā0.05 between 2 groups M0 (patients without distant metastasis) and M1 (patients with distant metastasis) (b), lymphatic metastasis after excluding the interference of distant metastasis (d),The significant ratios with Pā<ā0.05 between 2 groups (age >60 y and age ā¤60 y) (c) and another 2 groups (N1 and N2) number of lymphatic metastases (e).Back to article page